Immunogen Inc. (IMGN) Posts Q3 EPS Loss of $0.22
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Other (expense) income, net: 129K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Other (expense) income, net: 129K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Immunogen Inc. (NASDAQ: IMGN) reported Q3 EPS of ($0.22), $0.01 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $4.19 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
